vimarsana.com

Latest Breaking News On - துறை ஆஃப் இருதய மருந்து - Page 3 : vimarsana.com

Millennials Flock to Telehealth, Online Research

Millennials Flock to Telehealth, Online Research By Batya Swift Yasgur, MA April 2, 2021 The internet is often the first place many of us go to find information, whether it’s about hotels, music, or furniture. And health guidance is no exception especially among millennials. A new survey of 2,040 millennials (ages 23 to 39) in February by Harmony Healthcare IT found that 69% of respondents searched online for health and medical advice instead of going to the doctor, and a quarter of respondents trust Google to accurately diagnose their symptoms. Also, a strong majority (83%) are doing their own research, even after hearing advice from their doctor, and 42% trust their own research more than that of their doctor.

Cardiol Therapeutics Inc : Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A Cardiol Therapeutics Inc. ( a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, today filed its audited Financial Statements and Management s Discussion and Analysis for the year ended December 31, 2020. Both are available under the Company s profile on SEDAR at www.sedar.com and on the Company s website at www.cardiolrx.com. David Elsley, President and Chief Executive Officer of Cardiol, commented: 2020 was a very exciting year for Cardiol Therapeutics. We made extraordinary progress in our research and clinical development programs, while significantly strengthening our financial position. We are particularly excited about the progress made across our research and development programs supporting the development of CardiolRx, our pharmaceutically produced extra-strength oral f

Researchers develop mobile EKG device that can identify patients at risk of sudden cardiac death

Researchers develop mobile EKG device that can identify patients at risk of sudden cardiac death Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient s heart. The researchers determined that a smartphone-enabled mobile EKG device can rapidly and accurately determine a patient s QTc, thereby identifying patients at risk of sudden cardiac death from congenital long QT syndrome (LQTS) or drug-induced QT prolongation. The heart beats by a complex system of electrical signals triggering regular and necessary contractions. Clinicians evaluate the heart s rate-corrected QT interval, or QTc, as a vital health barometer of the heart s electrical recharging system. A potentially dangerous prolonged QTc, which is equal to or longer than 50 millis

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.